Home › Drug Codes › CPT Codes › 91321 · COVID-19 VACCINE 2023-2024
Updated October 1st, 2026

COVID-19 VACCINE 2023-2024 CPT Vaccine Code: 91321

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, 25 mcg/0.25 mL dosage, for intramuscular use

Login to unlock all benchmarks
Medicare Payment Limit ?
$172.967
2026–27 Season rate · per dose
CDC Cost / Dose ?
$•••.••
Login to view
Private Sector Cost / Dose ?
$•••.••
Login to view
WAC · AWP ?
$•••.••
Login to view
NDCs Crosswalked ?
4
View NDC crosswalk →
Medicare Coverage Medicare Part B covers COVID-19 VACCINE 2023-2024 as a preventive vaccine — the Part B deductible and coinsurance do not apply.

Vaccine & Product Overview

HCPCS Descriptor Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, 25 mcg/0.25 mL dosage, for intramuscular use
Manufacturer Moderna
Route of Administration Intramuscular
Generic Status Single-Source; Branded
Dosage Type Single-Dose
Dosage Form Injection, Suspension

About COVID-19 VACCINE 2023-2024

Covid-19 Vaccine 2023-2024 is a medication aligned to the HCPCS CPT Drug Code: 91321 for billing, pricing, and reimbursement purposes in the United States. Classified under Vaccine, it is administered via the intramuscular route and manufactured by Moderna.

According to CMS Drug Use Information: This vaccine is used to help prevent coronavirus disease, also known as COVID-19. It works by increasing the body's natural defense (immunity) against the virus. This vaccine may prevent the illness, or reduce the seriousness of it. Vaccines may not fully protect everyone who receives them.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

4 NDC packages are crosswalked to 91321. Package detail is available to logged-in subscribers.

NDC Code Drug Manufacturer Billing Units / Pkg Package Size
•••••-••••-•• Log in to view COVID-19 VACCINE 2023-2024
COVID-19 VACCINE 2023-2024
COVID-19 VACCINE 2023-2024
COVID-19 VACCINE 2023-2024
Login to view 4 NDC packages View pricing, complete NDC-to-HCPCS alignments, and package details.
Login →

COVID-19 VACCINE 2023-2024 Pricing & Reimbursement

91321 Private Payer Reimbursement
$148.34 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →
UnitedHealthcare, BlueCross BlueShield, Aetna, Cigna

Historical Graphing and Billing Calculator

per HCPCS unit
As of Q4 2026

Medicare vaccine payment limits reset each season (effective August 1) — year-over-year steps in the chart reflect the new season's pricing, not data errors.

COVID-19 VACCINE 2023-2024 Vaccine Administration Codes

The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.

CPT Code Description
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), one vaccine (single or combination vaccine/toxoid)
90472 Immunization administration (each additional vaccine or toxoid), when performed in conjunction with primary procedure.

COVID-19 VACCINE 2023-2024 Medically Unlikely Edits (MUE)

The most billing units of 91321 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 0.25 ml.

Practitioner Office & Hospital Outpatient
1 unit / day
= 0.25 ml per day

MAI 2 · Date of Service Edit: Policy. Absolute per-day limit set by policy or regulation; units above it are not payable, and denials are not appealable on medical-necessity grounds. See all MUE limits →

ml Enter a dose to see how many billing units it is and whether it is under the limit.

COVID-19 VACCINE 2023-2024 Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

COVID-19

Login for BuyandBill.com Analytics

Unlock deeper insights with BuyandBill’s Comparative Report!

  • Compare ASP, WAC, and AWP across drugs.
  • Visualize Drug Price Movement Over Time
  • Tailor reports to drug class, manufacturer, or HCPCS Code.
  • Compare Biosimilar and 505(b)(2) products.
Access Full Report →

Frequently Asked Questions

Is there a manufacturer-published billing and coding guide for Covid-19 Vaccine 2023-2024?
Billing and coding information for COVID-19 VACCINE 2023-2024 can be found through Moderna. Visit Here →
Are there any available patient assistance programs for Covid-19 Vaccine 2023-2024?
COVID-19 VACCINE 2023-2024 patient assistance information can be found through Moderna. Visit Here →
Where can I find Covid-19 Vaccine 2023-2024 prescribing information?
Our team has not identified a source of prescribing information for this medication
Is there available side effect information for Covid-19 Vaccine 2023-2024?
Our team has not identified a source of side effect information for Covid-19 Vaccine 2023-2024.
Does billing COVID-19 VACCINE 2023-2024 require JZ/JW wastage modifiers?
CMS does not include COVID-19 VACCINE 2023-2024 (91321) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing 91321. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.

Related Drug Codes

Explore billing, coding, and pricing for drugs related to COVID-19 VACCINE 2023-2024.

91320COMIRNATY 2023-2024 AGE 12 AND OLDERSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, 30 mcg/0.3 mL dosage, tris-sucrose formulation, for intramuscular usePfizer91319PFIZER-BIONTECH COVID-19 VACCINE 2023-2024 AGE5<12Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, 10 mcg/0.3 mL dosage, tris-sucrose formulation, for intramuscular usePfizer91322SPIKEVAX 2023-2024 FORMULASevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, 50 mcg/0.5 mL dosage, for intramuscular useModerna91323mNEXSPIKE 2025-26 (12Y UP)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, 10 mcg/0.2 mL dosage, for intramuscular useModerna91304NOVAVAX COVID-19 VACCINE, 2023-2024 ADJUVANTEDSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, 5 mcg/0.5 mL dosage, for intramuscular useNovavaxJ0248VEKLURYInjection, remdesivir, 1 mgGilead SciencesAdded December 23, 202190371HYPERHEP BHepatitis B immune globulin (HBIg), human, for intramuscular useMultiple Manufacturers90375HYPERRABRabies immune globulin (RIg), human, for intramuscular and/or subcutaneous useGrifols90376IMOGAM RABIES-HTRabies immune globulin, heat-treated (RIg-HT), human, for intramuscular and/or subcutaneous useSanofi90377KEDRABRabies ig ht&sol human im/scKedrion Biopharma